Adeshwar Meditex FY26 net profit at Rs 126.49 lakh

adeshwar meditex has announced the outcome of its board meeting held on May 21, 2026. The board approved the audited financial results for the half year and financial year ended March 31, 2026. The statutory auditors issued an unmodified opinion on the results.

Financial Performance

For the financial year ended March 31, 2026, the company reported a net profit of Rs 126.49 lakh, a decrease from Rs 206.57 lakh in the previous year. Revenue from operations stood at Rs 5,610.38 lakh, down from Rs 8,371.31 lakh in FY25. Total income for the year was Rs 5,620.76 lakh.

For the half year ended March 31, 2026, the net profit was Rs 53.38 lakh on a total income of Rs 2,609.77 lakh.

Particulars	Year Ended 31.03.2026 (Audited)	Year Ended 31.03.2025 (Audited)
Revenue From Operations	5,610.38	8,371.31
Total Income	5,620.76	8,397.17
Total Expenses	5,437.57	8,117.83
Net Profit	126.49	206.57

Board Decisions

In addition to the financial results, the board took note of the resignation of Mr. Arun Koli from the post of Independent Director. The board approved the appointment of Ms. Bhagyalaxmi Kavital as an Additional (Non-Executive) Independent Director. The directors also discussed raising funds up to Rs 40 Crores by way of further issue of Equity shares and the acceptance of director's loans or borrowing funds in the form of debentures.

Compliance and Trading Window

The trading window for the company's securities, which was closed since April 1, 2026, will reopen 48 hours after the announcement of the financial results. The intimation regarding the board meeting was submitted to BSE Limited in compliance with Regulation 29 and 33 of the SEBI (LODR) Regulations, 2015.

Adeshwar Meditex Limited announced the reappointment of M/s. Basude Makote & Saini, Chartered Accountants, as its Internal Auditors for the financial years 2025-26 to 2027-28. The decision was taken at a Board of Directors meeting held on May 14, 2026, commencing at 4:00 PM (IST) and concluding at 4:30 PM (IST). The reappointment was made pursuant to Section 138 of the Companies Act, 2013, and the disclosure was submitted to BSE Limited under Regulation 30 of the SEBI (LODR) Regulations, 2015.

Reappointment Details

The following key details of the reappointment were disclosed by the company:

Parameter:	Details
Name of Internal Auditors:	M/s. Basude Makote & Saini
FRN No.:	124381W
Membership No.:	183122
Date of Appointment:	May 14, 2026
Tenure:	FY 2025-26 to FY 2027-28
Internal Auditor Since:	August 26, 2023
Statutory Basis:	Section 138 of the Companies Act, 2013

Profile of M/s. Basude Makote & Saini

M/s. Basude Makote & Saini is a well-established Chartered Accountant firm with extensive experience working with corporate entities, LLPs, partnership firms, banks, and co-operatives. The firm offers a broad range of professional services, as highlighted below:

Statutory Audit and Internal Audit
Stock Audit and Forensic Audit
Project Financing
Direct and Indirect Tax Consultancy
Due Diligence and Legal Services
Preparation and Finalization of Balance Sheets for companies, firms, educational institutions, and other organizations
Reconciliation of Accounts
Extensive litigation before appeal

The firm is also engaged in rendering legal and due diligence services to various industries and corporates across the country.

Board Authorization

The reappointment was authorized by Krishnojirao Nagaraja Rao, Whole-time Director (DIN: 07684308), on behalf of Adeshwar Meditex Limited. The company noted that there is no disclosure of relationships between directors applicable in this case, as the appointment pertains to an auditing firm and not a director. The outcome of the board meeting was communicated to BSE Limited for record purposes in compliance with applicable regulatory requirements.